Role of Soluble Epoxide Hydrolase in Exacerbation of Stroke by Streptozotocin-Induced Type 1 Diabetes Mellitus

Diabetes Mellitus, Acute Hyperglycemia, and Ischemic Stroke

(2010) Askiel Bruno et al.   Current Treatment Options in Neurology

Inhibition of Soluble Epoxide Hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid Is Protective Against Ischemia–Reperfusion Injury

(2010) Ketul R Chaudhary et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Hyperglycaemia and Infarct Size in Animal Models of Middle Cerebral Artery Occlusion: Systematic Review and Meta-Analysis

(2010) Niall J J MacDougall et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Epoxyeicosatrienoic acids are endogenous regulators of vasoactive neuropeptide release from trigeminal ganglion neurons

(2010) Jeffrey J. Iliff et al.   JOURNAL OF NEUROCHEMISTRY

Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis

(2010) P. Luo et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Persistent Hyperglycemia >155 mg/dL in Acute Ischemic Stroke Patients: How Well Are We Correcting It?

(2010) Blanca Fuentes et al.   STROKE

Hyperglycaemia in acute ischaemic stroke is associated with an increased 5-year mortality

(2009) N. Kostulas et al.   AGE AND AGEING

Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection

(2009) Alexis N. Simpkins et al.   AMERICAN JOURNAL OF PATHOLOGY

Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling

(2009) Matthias J. Merkel et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation

(2009) Jun-Yan Liu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Regulation of Soluble Epoxide Hydrolase (sEH) in Mice with Diabetes: High Glucose Suppresses sEH Expression

(2009) Ami Oguro et al.   Drug Metabolism and Pharmacokinetics

Role of Soluble Epoxide Hydrolase in the Sex-Specific Vascular Response to Cerebral Ischemia

(2009) Wenri Zhang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism

(2009) A. Marowsky et al.   NEUROSCIENCE

Intensive versus Conventional Glucose Control in Critically Ill Patients

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Epoxyeicosanoid signaling in CNS function and disease

(2009) Jeffrey J. Iliff et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo

(2008) Atsuko Motoki et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study

(2008) Elizabeth A. Spencer et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Distribution and Expression of Soluble Epoxide Hydrolase in Human Brain

(2008) Priyanka Sura et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Hyperglycemia as An Independent Predictor of Worse Outcome in Non-diabetic Patients Presenting with Acute Ischemic Stroke

(2008) Latha G. Stead et al.   Neurocritical Care

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia

(2008) Wenri Zhang et al.   STROKE

Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia

(2007) Ines et al.   Frontiers in Bioscience-Landmark

Altered Soluble Epoxide Hydrolase Gene Expression and Function and Vascular Disease Risk in the Stroke-Prone Spontaneously Hypertensive Rat

(2007) Mandi J. Corenblum et al.   HYPERTENSION